Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Stocks
Currencies
Cryptocurrencies
Metals
Indices
Commodities
ETFs
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
News
Top Providers News
Top Providers News
Symbols
Market
Provider
Time
Symbols
News
Provider
2026.11.02
Clorox Affirms FY2027 GAAP EPS Guidance of $5.41-$5.71 vs $5.70 Est
Benzinga
2026.11.02
Fabrinet Q1 Adj. EPS $4.34 Beats $4.19 Estimate, Sales $1.474B Beat $1.403B Estimate
Benzinga
2026.11.02
ONE Gas Q3 Adj. EPS $0.53 Beats $0.47 Estimate, Sales $391.313M Miss $398.950M Estimate
Benzinga
2026.11.02
Celanese Q3 Adj. EPS $1.65 Beats $1.57 Estimate, Sales $2.556B Miss $2.624B Estimate
Benzinga
2026.11.02
Centerspace Q3 FFO $0.83 Misses $1.14 Estimate, Sales $59.500M Miss $63.329M Estimate
Benzinga
2026.11.02
Archrock Q3 Adj. EPS $0.49 Beats $0.46 Estimate, Sales $370.811M Miss $385.954M Estimate
Benzinga
2026.11.02
ON Semiconductor Q3 Adj. EPS $0.90 Beats $0.88 Estimate, Sales $1.722B Beat $1.703B Estimate
Benzinga
2026.11.02
Match Group Q3 EPS $0.73 Beats $0.72 Estimate, Sales $891.232M Miss $892.468M Estimate
Benzinga
2026.11.02
Barclays Maintains Overweight on Veralto, Raises Price Target to $129
Benzinga
2026.11.02
SI-BONE Affirms FY2026 Sales Guidance of $231.000M-$233.000M vs $232.024M Est
Benzinga
2026.11.02
Keysight Technologies Appoints Jason Kary CFO, Effective Dec. 18, Succeeding Neil Dougherty
Benzinga
2026.11.02
Palantir Technologies CEO Says Sovereign AI Movement Is Imposing the Most Dramatic Dichotomy Between Haves and Have Nots That I Have Witnessed in 30 Years of Business; Every Institution, Government And Commercial, Is Rapidly Being Forced, Voluntarily or...
Benzinga
2026.11.02
Harmonic Raises FY2026 GAAP EPS Guidance from $0.44-$0.53 to $0.54-$0.57 vs $0.50 Est; Raises FY2026 Sales Guidance from $505.000M-$525.000M to $545.000M-$555.000M
Benzinga
2026.11.02
BWX Technologies Narrows FY2026 Adj EPS Guidance from $4.70-$4.80 to $4.72-$4.77 vs $4.74 Est; Affirms FY2026 Sales Guidance of $3.800B vs $3.807B Est
Benzinga
2026.11.02
Harmonic Raises FY2026 Adj EPS Guidance from $0.67-$0.75 to $0.80-$0.84 vs $0.71 Est; Sees Sales $545.000M-$555.000M vs $517.275M Est
Benzinga
2026.11.02
POMDOCTOR Receives Nasdaq Noncompliance Notice, Gets Time Through April 26, 2027 To Regain Compliance
Benzinga
2026.11.02
Williams Companies Affirms FY2026 Adj EPS Guidance of $2.35 vs $2.40 Est
Benzinga
2026.11.02
UPDATE: Adeia Lowers FY2026 GAAP EPS Guidance from $0.50-$0.70 to $0.47-$0.69 vs $0.66 Est; Lowers FY2026 Sales Guidance from $395.000M-$435.000M to $375.000M-$415.000M
Benzinga
2026.11.02
Waystar Holding Q3 Adj. EPS $0.44 Beats $0.41 Estimate, Sales $325.624M Beat $323.401M Estimate
Benzinga
2026.11.02
Harmonic Sees Q4 GAAP EPS $0.13-$0.16 vs $0.12 Est; Sees Sales $141.000M-$151.000M
Benzinga
2026.11.02
Recursion Appoints Fred Hassan As Board Chair, Effective Oct. 31
Benzinga
2026.11.02
Harmonic Sees Q4 Adj EPS $0.19-$0.23 vs $0.17 Est; Sees Sales $141.000M-$151.000M vs $131.276M Est
Benzinga
2026.11.02
Independence Realty Trust Affirms FY2026 FFO Guidance of $1.13-$1.15 vs $1.15 Est
Benzinga
2026.11.02
Neurocrine Biosciences Q3 Adj. EPS $3.29 Beats $1.91 Estimate, Sales $1.119B Beat $1.043B Estimate
Benzinga
2026.11.02
Realty Income Raises FY2026 FFO Guidance from $4.44-$4.45 to $4.45-$4.46 vs $4.37 Est
Benzinga
2026.11.02
Tactile Systems Tech Q3 EPS $0.31 Misses $0.35 Estimate, Sales $91.858M Miss $91.993M Estimate
Benzinga
2026.11.02
People Incorporated - Common Stock Q3 EPS $(9.15) Misses $(0.19) Estimate, Sales $430.820M Miss $442.412M Estimate
Benzinga
2026.11.02
CRISPR Therapeutics Q3 EPS $(1.15) Misses $(0.98) Estimate, Sales $12.669M Beat $10.495M Estimate
Benzinga
2026.11.02
Adeia Lowers FY2026 GAAP Sales Guidance from $395.000M-$435.000M to $375.000M-$415.000M
Benzinga
2026.11.02
Hinge Health Raises FY2026 Sales Guidance from $856.000M-$860.000M to $879.000M-$881.000M vs $861.558M Est
Benzinga
1
...
317
318
319
320
321
322
...
709
>